Background/Aims: The medical term "Health related Quality of Life (HRQOL)", a subjective index of a patient's health status, has been used as an index for the treatment in wide variety of chronic diseases. Although HRQOL is known to decrease in patients with primary biliary cirrhosis (PBC), there has been no study using a disease specific HRQOL questionnaire for PBC. Recently, Jacoby
et al. developed a disease specific questionnaire for PBC (named PBC-40) and reported its usefulness in European patients. Because no such report using PBC-40 has been reported from Japan, we evaluated the usefulness of the PBC-40 questionnaire for Japanese patients.
Methods: We drafted a Japanese language version of the PBC-40 questionnaire from the original version established by Jacoby, and sent it to 44 patients with PBC at Gunma University Hospital and affiliated hospitals during the period from October through December, 2007. Clinical characteristics and blood chemistry findings were also evaluated and compared with the PBC-40 results.
Results: Mean age of the 44 patients who completed the PBC-40 was 60.9 ± 9.9 years old, and male/female ratio was 1:4.5. Of these patients, 27 were asymptomatic PBC while 17 were symptomatic PBC. The mean total score of PBC-40 was 84.0 ± 28.6, with a significant difference between asymptomatic and symptomatic groups of patients: 72.8 ± 18.6 vs 102.1 ± 33.1, P<0.01. Mean score for each category of PBC-40 was as follows; symptoms 2.0, itching 1.9, fatigue 2.2, cognition 2.0, social 2.0 and emotional 2.9. The emotional score was significantly higher than the other 5 categories (P<0.01). All scores for the 6 subcategories were significantly higher in patients with symptomatic PBC than in those with asymptomatic PBC. According to Spearman's rank correlation, the PBC-40 score showed a significantly positive correlation with alkaline phosphatase (ALP) and total bile acids, and a negative correlation with hemoglobin, prothrombin time, and anti-mitochondrial antibody (AMA) titer (P<0.05). A multiple regression analysis indicated that all of the ALP, total bile acids and AMA titer were significant factors which influenced the PBC-40 scores in our patients (P<0.05).
Conclusion: The PBC-40 score was thus found to be significantly higher in the symptomatic PBC patients than in asymptomatic patient. This subjective score was well correlated to the objective indices of disease progression in PBC. The Japanese version of PBC-40 would be useful for accurately assessing the HRQOL in Japanese patients with PBC.
View full abstract